Hepatic Dysfunction Caused by Consumption of a High-Fat Diet

Cell Reports

Volumn 21, Issue 11, 2017, Pages 3317-3328

  Soltis, Anthony R ^a   Kennedy, Norman J ^b   Xin, Xiaofeng ^a,g   Zhou, Feng ^c,d,e   Ficarro, Scott B ^c,d,e   Yap, Yoon Sing ^a   Matthews, Bryan J ^a   Lauffenburger, Douglas A ^a   White, Forest M ^a   Marto, Jarrod A ^c,d,e   Davis, Roger J ^b,f   Fraenkel, Ernest ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

computational biology; high fat diet; insulin resistance; integrative modeling; obesity; omic data; systems biology

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOARCHITECTURE; DISEASE COURSE; EPIGENETICS; FAT INTAKE; GENE EXPRESSION; HEPATITIS; HIGH THROUGHPUT SCREENING; HISTOLOGY; IMAGE ANALYSIS; IMMUNOBLOTTING; INSULIN RESISTANCE; LIPID DIET; LIVER CELL; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TISSUE; MALE; METABOLIC SYNDROME X; METABOLISM; METABOLOMICS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEOMICS; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LIVER; METABOLOME; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; ULTRASTRUCTURE;

INSULIN; TRANSCRIPTOME;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; DIET, HIGH-FAT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEPATOCYTES; INSULIN; INSULIN RESISTANCE; LIVER; MALE; METABOLOME; MICE; MICE, INBRED C57BL; OBESITY; PROTEIN INTERACTION MAPPING; TRANSCRIPTOME;

EID: 85037820239     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.11.059     Document Type: Article

References (66)

1. Anders, S., Huber, W., Differential expression analysis for sequence count data. Genome Biol., 11, 2010, R106.
2. Azimifar, S.B., Nagaraj, N., Cox, J., Mann, M., Cell-type-resolved quantitative proteomics of murine liver. Cell Metab. 20 (2014), 1076–1087.
3. Blondel, V.D., Guillaume, J.-L., Lambiotte, R., Lefebvre, E., Fast unfolding of communities in large networks. J. Stat. Mech., 2008, 2008, P10008.
4. Brown, M.S., Goldstein, J.L., Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7 (2008), 95–96.
5. Carpenter, A.E., Jones, T.R., Lamprecht, M.R., Clarke, C., Kang, I.H., Friman, O., Guertin, D.A., Chang, J.H., Lindquist, R.A., Moffat, J., et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol., 7, 2006, R100.
6. Choe, C.U., Nabuurs, C., Stockebrand, M.C., Neu, A., Nunes, P., Morellini, F., Sauter, K., Schillemeit, S., Hermans-Borgmeyer, I., Marescau, B., et al. L-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome. Hum. Mol. Genet. 22 (2013), 110–123.
7. Collins, S., Martin, T.L., Surwit, R.S., Robidoux, J., Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol. Behav. 81 (2004), 243–248.
8. Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107 (2010), 21931–21936.
9. Daimon, M., Oizumi, T., Karasawa, S., Kaino, W., Takase, K., Tada, K., Jimbu, Y., Wada, K., Kameda, W., Susa, S., et al. Association of the clusterin gene polymorphisms with type 2 diabetes mellitus. Metabolism 60 (2011), 815–822.
10. DeFronzo, R.A., Gunnarsson, R., Björkman, O., Olsson, M., Wahren, J., Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76 (1985), 149–155.
11. Dunn, W.B., Broadhurst, D.I., Atherton, H.J., Goodacre, R., Griffin, J.L., Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40 (2011), 387–426.
12. Eckel-Mahan, K.L., Patel, V.R., de Mateo, S., Orozco-Solis, R., Ceglia, N.J., Sahar, S., Dilag-Penilla, S.A., Dyar, K.A., Baldi, P., Sassone-Corsi, P., Reprogramming of the circadian clock by nutritional challenge. Cell 155 (2013), 1464–1478.
13. Flegal, K.M., Kit, B.K., Orpana, H., Graubard, B.I., Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309 (2013), 71–82.
14. Guicciardi, M.E., Gores, G.J., Apoptosis: a mechanism of acute and chronic liver injury. Gut 54 (2005), 1024–1033.
15. Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006), 840–846.
16. Kang, L., Lantier, L., Kennedy, A., Bonner, J.S., Mayes, W.H., Bracy, D.P., Bookbinder, L.H., Hasty, A.H., Thompson, C.B., Wasserman, D.H., Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance. Diabetes 62 (2013), 1888–1896.
17. Kitano, H., Systems biology: a brief overview. Science 295 (2002), 1662–1664.
18. Kwon, M.J., Ju, T.J., Heo, J.Y., Kim, Y.W., Kim, J.Y., Won, K.C., Kim, J.R., Bae, Y.K., Park, I.S., Min, B.H., et al. Deficiency of clusterin exacerbates high-fat diet-induced insulin resistance in male mice. Endocrinology 155 (2014), 2089–2101.
19. Langmead, B., Aligning short sequencing reads with Bowtie. Curr. Protoc. Bioinformatics, Chapter 11, 2010 Unit 11.7.
20. Lee, S.C., Pervaiz, S., Apoptosis in the pathophysiology of diabetes mellitus. Int. J. Biochem. Cell Biol. 39 (2007), 497–504.
21. Leung, A., Parks, B.W., Du, J., Trac, C., Setten, R., Chen, Y., Brown, K., Lusis, A.J., Natarajan, R., Schones, D.E., Open chromatin profiling in mice livers reveals unique chromatin variations induced by high fat diet. J. Biol. Chem. 289 (2014), 23557–23567.
22. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
23. Lu, M., Wan, M., Leavens, K.F., Chu, Q., Monks, B.R., Fernandez, S., Ahima, R.S., Ueki, K., Kahn, C.R., Birnbaum, M.J., Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18 (2012), 388–395.
24. Lusis, A.J., Attie, A.D., Reue, K., Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet. 9 (2008), 819–830.
25. Metzker, M.L., Sequencing technologies – the next generation. Nat. Rev. Genet. 11 (2010), 31–46.
26. Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnuson, M.A., Kahn, C.R., Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6 (2000), 87–97.
27. Miraldi, E.R., Sharfi, H., Friedline, R.H., Johnson, H., Zhang, T., Lau, K.S., Ko, H.J., Curran, T.G., Haigis, K.M., Yaffe, M.B., et al. Molecular network analysis of phosphotyrosine and lipid metabolism in hepatic PTP1b deletion mice. Integr. Biol. 5 (2013), 940–963.
28. Nikiforova, V.J., Giesbertz, P., Wiemer, J., Bethan, B., Looser, R., Liebenberg, V., Ruiz Noppinger, P., Daniel, H., Rein, D., Glyoxylate, a new marker metabolite of type 2 diabetes. J. Diabetes Res., 2014, 2014, 685204.
29. Oberbach, A., Blüher, M., Wirth, H., Till, H., Kovacs, P., Kullnick, Y., Schlichting, N., Tomm, J.M., Rolle-Kampczyk, U., Murugaiyan, J., et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J. Proteome Res. 10 (2011), 4769–4788.
30. Paull, E.O., Carlin, D.E., Niepel, M., Sorger, P.K., Haussler, D., Stuart, J.M., Discovering causal pathways linking genomic events to transcriptional states using Tied Diffusion Through Interacting Events (TieDIE). Bioinformatics 29 (2013), 2757–2764.
31. Perry, R.J., Camporez, J.P., Kursawe, R., Titchenell, P.M., Zhang, D., Perry, C.J., Jurczak, M.J., Abudukadier, A., Han, M.S., Zhang, X.M., et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160 (2015), 745–758.
32. Pilkis, S.J., Granner, D.K., Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 54 (1992), 885–909.
33. Piñero, J., Queralt-Rosinach, N., Bravo, À., Deu-Pons, J., Bauer-Mehren, A., Baron, M., Sanz, F., Furlong, L.I., DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (Oxford), 2015, 2015, bav028.
34. Pyo, J.O., Jang, M.H., Kwon, Y.K., Lee, H.J., Jun, J.I., Woo, H.N., Cho, D.H., Choi, B., Lee, H., Kim, J.H., et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J. Biol. Chem. 280 (2005), 20722–20729.
35. Ramachandran, P., Henderson, N.C., Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol. Hepatol. 1 (2016), 328–340.
36. Ramsey, S.A., Knijnenburg, T.A., Kennedy, K.A., Zak, D.E., Gilchrist, M., Gold, E.S., Johnson, C.D., Lampano, A.E., Litvak, V., Navarro, G., et al. Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites. Bioinformatics 26 (2010), 2071–2075.
37. Razick, S., Magklaras, G., Donaldson, I.M., iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics, 9, 2008, 405.
38. Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J.Y., Ko, H.J., Barrett, T., Kim, J.K., Davis, R.J., A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322 (2008), 1539–1543.
39. Santos-Rosa, H., Schneider, R., Bannister, A.J., Sherriff, J., Bernstein, B.E., Emre, N.C., Schreiber, S.L., Mellor, J., Kouzarides, T., Active genes are tri-methylated at K4 of histone H3. Nature 419 (2002), 407–411.
40. Schattenberg, J.M., Schuchmann, M., Diabetes and apoptosis: liver. Apoptosis 14 (2009), 1459–1471.
41. Schrem, H., Klempnauer, J., Borlak, J., Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 54 (2002), 129–158.
42. Schrem, H., Klempnauer, J., Borlak, J., Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 56 (2004), 291–330.
43. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., Selbach, M., Global quantification of mammalian gene expression control. Nature 473 (2011), 337–342.
44. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B., Ideker, T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (2003), 2498–2504.
45. Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S., Goldstein, J.L., Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6 (2000), 77–86.
46. Thiele, I., Swainston, N., Fleming, R.M., Hoppe, A., Sahoo, S., Aurich, M.K., Haraldsdottir, H., Mo, M.L., Rolfsson, O., Stobbe, M.D., et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31 (2013), 419–425.
47. Titchenell, P.M., Chu, Q., Monks, B.R., Birnbaum, M.J., Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nat. Commun., 6, 2015, 7078.
48. Titchenell, P.M., Quinn, W.J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B.R., Chen, J., Rabinowitz, J.D., Birnbaum, M.J., Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production. Cell Metab. 23 (2016), 1154–1166.
49. Trapnell, C., Pachter, L., Salzberg, S.L., TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25 (2009), 1105–1111.
50. Tuncbag, N., Braunstein, A., Pagnani, A., Huang, S.S., Chayes, J., Borgs, C., Zecchina, R., Fraenkel, E., Simultaneous reconstruction of multiple signaling pathways via the prize-collecting steiner forest problem. J. Comput. Biol. 20 (2013), 124–136.
51. Tuncbag, N., Gosline, S.J., Kedaigle, A., Soltis, A.R., Gitter, A., Fraenkel, E., Network-based interpretation of diverse high-throughput datasets through the Omics Integrator software package. PLoS Comput. Biol., 12, 2016, e1004879.
52. Villaveces, J.M., Jiménez, R.C., Porras, P., Del-Toro, N., Duesbury, M., Dumousseau, M., Orchard, S., Choi, H., Ping, P., Zong, N.C., et al. Merging and scoring molecular interactions utilising existing community standards: tools, use-cases and a case study. Database (Oxford), 2015, 2015, bau131.
53. Viollet, B., Foretz, M., Revisiting the mechanisms of metformin action in the liver. Ann. Endocrinol. (Paris) 74 (2013), 123–129.
54. Wamstad, J.A., Alexander, J.M., Truty, R.M., Shrikumar, A., Li, F., Eilertson, K.E., Ding, H., Wylie, J.N., Pico, A.R., Capra, J.A., et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151 (2012), 206–220.
55. Wang, K., Molecular mechanisms of hepatic apoptosis. Cell Death Dis., 5, 2014, e996.
56. Wang, J., Chun, H.J., Wong, W., Spencer, D.M., Lenardo, M.J., Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA 98 (2001), 13884–13888.
57. Wang, Z., Shah, O.J., Hunter, T., The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models. PLoS ONE, 7, 2012, e36961.
58. Williams, A.S., Kang, L., Wasserman, D.H., The extracellular matrix and insulin resistance. Trends Endocrinol. Metab. 26 (2015), 357–366.
59. Williams, A.S., Kang, L., Zheng, J., Grueter, C., Bracy, D.P., James, F.D., Pozzi, A., Wasserman, D.H., Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance. J. Biol. Chem. 290 (2015), 6546–6557.
60. Wingender, E., Dietze, P., Karas, H., Knüppel, R., TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res. 24 (1996), 238–241.
61. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. HMDB 3.0–The Human Metabolome Database in 2013. Nucleic Acids Res. 41 (2013), D801–D807.
62. Wu, Y., Williams, E.G., Dubuis, S., Mottis, A., Jovaisaite, V., Houten, S.M., Argmann, C.A., Faridi, P., Wolski, W., Kutalik, Z., et al. Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population. Cell 158 (2014), 1415–1430.
63. Yizhak, K., Benyamini, T., Liebermeister, W., Ruppin, E., Shlomi, T., Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics 26 (2010), i255–i260.
64. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., Liu, X.S., Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, 2008, R137.
65. Zhao, Y., Barrere-Cain, R.E., Yang, X., Nutritional systems biology of type 2 diabetes. Genes Nutr., 10, 2015, 481.
66. Zhou, F., Lu, Y., Ficarro, S.B., Adelmant, G., Jiang, W., Luckey, C.J., Marto, J.A., Genome-scale proteome quantification by DEEP SEQ mass spectrometry. Nat. Commun., 4, 2013, 2171.